Purpose: Current and future treatment modalities for Clostridium difficile-associated disease (CDAD) are reviewed. Conclusion: CDAD is a major concern for health care systems and clinicians.

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...

Dogs trained to detect bladder cancer showed 90% sensitivity and 95% specificity, offering a non-invasive diagnostic method.

There has been an 'alarming decline' in the overall quality of NHS care, with the deterioration in maternity services particularly bad, a report reveals.

The Global Hospital Gowns Market is anticipated to experience robust growth, estimated at a Compound Annual Growth Rate (CAGR) of approximately 10.7% throughout the forecast period spanning 2020-2025.

Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...

Proton pump inhibitors (PPIs) are a type of medication that reduces how much acid your stomach produces. Doctors prescribe PPIs to treat stomach ulcers and symptoms of chronic acid reflux, also known ...

The intricate relationship between human and pet microbiomes represents a fascinating and highly relevant area of study for ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...

Difficile treatment, Ser-109. Also notable among the many innovations which could be approved in 2023 is significant progress in Respiratory Syncytial Virus (RSV), a common respiratory infection ...